Valeur Intrinsèque du S&P et Nasdaq Contactez-nous
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Retour aux actions

Cepheid CPHD NASDAQ

NASDAQ • Healthcare • Biotechnology • USD

SharesGrow Score
30/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Il y a eu 50 transactions d'initiés récentes enregistrées pour Cepheid (CPHD), dont 11 achats et 38 ventes. Le total des achats d'initiés s'élève à $1.84M et le total des ventes d'initiés à $11.28M.

Les initiés notables ayant une activité récente comprennent Renton Hollings, Bishop John L, Steele Glenn Jr Md Phd. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — CPHD

Date Nom Rôle Type de Transaction Actions Prix Moyen Valeur Actions détenues
2016-11-04 Renton Hollings Director Restitution d'Actions 16,300 $36.59 $596.42K -
2016-11-04 Bishop John L Chairman of the Board and CEO Restitution d'Actions 150,000 $35.94 $5.39M -
2016-11-04 Steele Glenn Jr Md Phd Director Restitution d'Actions 16,300 $36.59 $596.42K -
2016-11-04 Madden Dan EVP, Chief Financial Officer Restitution d'Actions 50,500 $35.94 $1.81M -
2016-10-31 Renton Hollings Director Don (Donné) 3,350 $52.90 $177.22K 11,567
2016-10-29 Bishop John L Chairman of the Board and CEO Exercice d'Options (Vente) 1,219 - - 2,438
2016-10-27 Bishop John L Chairman of the Board and CEO Retenue Fiscale RSU 751 $52.92 $39.74K 82,427
2016-10-27 Madden Dan EVP, Chief Financial Officer Retenue Fiscale RSU 44 $52.92 $2.33K 9,748
2016-10-21 Bishop John L Chairman of the Board and CEO Exercice d'Options (Vente) 1,219 - - 7,313
2016-10-12 Madden Dan EVP, Chief Financial Officer Retenue Fiscale RSU 59 $52.69 $3.11K 9,792
2016-09-02 Madden Dan EVP, Chief Financial Officer Retenue Fiscale RSU 47 $34.42 $1.62K 9,851
2016-08-13 Madden Dan EVP, Chief Financial Officer Retenue Fiscale RSU 470 $35.73 $16.79K 9,898
2016-07-29 Bishop John L Chairman of the Board and CEO Exercice d'Options (Vente) 1,218 - - 3,657
2016-07-27 Bishop John L Chairman of the Board and CEO Retenue Fiscale RSU 750 $33.10 $24.83K 81,862
2016-07-27 Madden Dan EVP, Chief Financial Officer Retenue Fiscale RSU 44 $33.10 $1.46K 10,368
2016-07-26 Bishop John L Chairman of the Board and CEO Attribution de RSU 75,000 - - 75,000
2016-07-26 Madden Dan EVP, Chief Financial Officer Attribution de RSU 25,250 - - 25,250
2016-07-21 Bishop John L Chairman of the Board and CEO Exercice d'Options (Vente) 1,218 - - 8,532
2016-07-12 Madden Dan EVP, Chief Financial Officer Retenue Fiscale RSU 59 $34.20 $2.02K 10,412
2016-06-02 Madden Dan EVP, Chief Financial Officer Retenue Fiscale RSU 47 $28.89 $1.36K 10,471
2016-04-29 Bishop John L Chairman of the Board and CEO Exercice d'Options (Vente) 1,219 - - 4,875
2016-04-27 Bishop John L Chairman of the Board and CEO Retenue Fiscale RSU 3,001 $36.57 $109.75K 81,448
2016-04-27 Madden Dan EVP, Chief Financial Officer Retenue Fiscale RSU 174 $36.57 $6.36K 10,518
2016-04-26 Renton Hollings Director Attribution de RSU 1,800 - - 14,917
2016-04-26 Steele Glenn Jr Md Phd Director Attribution de RSU 1,800 - - 14,677
2016-04-25 Bishop John L Chairman of the Board and CEO Exercice d'Options (Vente) 110,000 $8.43 $927.3K -
2016-04-25 Madden Dan EVP, Chief Financial Officer Attribution de RSU 50,500 $35.94 $1.81M 50,500
2016-04-24 Bishop John L Chairman of the Board and CEO Exercice d'Options (Vente) 1,063 - - -
2016-04-21 Bishop John L Chairman of the Board and CEO Exercice d'Options (Vente) 1,219 - - 9,750
2016-04-12 Madden Dan EVP, Chief Financial Officer Retenue Fiscale RSU 59 $34.17 $2.02K 10,692
2016-03-02 Madden Dan EVP, Chief Financial Officer Retenue Fiscale RSU 47 $32.10 $1.51K 10,751
2016-01-29 Bishop John L Chairman of the Board and CEO Exercice d'Options (Vente) 1,219 - - 6,094
2016-01-24 Bishop John L Chairman of the Board and CEO Exercice d'Options (Vente) 1,062 - - 1,063
2016-01-21 Bishop John L Chairman of the Board and CEO Exercice d'Options (Vente) 1,219 - - 10,969
2016-01-12 Madden Dan EVP, Chief Financial Officer Cession 16,500 $56.06 $924.99K -
2016-01-12 Madden Dan EVP, Chief Financial Officer Retenue Fiscale RSU 274 $34.60 $9.48K 10,798
2015-12-02 Madden Dan EVP, Chief Financial Officer Retenue Fiscale RSU 47 $32.64 $1.53K 11,072
2015-10-29 Bishop John L Chairman of the Board and CEO Exercice d'Options (Vente) 1,219 - - 7,313
2015-10-24 Bishop John L Chairman of the Board and CEO Exercice d'Options (Vente) 1,063 - - 2,125
2015-10-21 Bishop John L Chairman of the Board and CEO Exercice d'Options (Vente) 1,219 - - 12,188
2015-09-02 Madden Dan EVP, Chief Financial Officer Retenue Fiscale RSU 47 $48.44 $2.28K 11,119
2015-08-13 Madden Dan EVP, Chief Financial Officer Attribution de RSU 5,000 - - 11,166
2015-08-13 Madden Dan EVP, Chief Financial Officer Cession - - - 6,166
2015-08-10 Steele Glenn Jr Md Phd Director Attribution de RSU 161 $51.84 $8.35K 12,877
2015-07-29 Bishop John L Chairman of the Board and CEO Exercice d'Options (Vente) 1,218 - - 8,532
2015-07-24 Bishop John L Chairman of the Board and CEO Exercice d'Options (Vente) 1,062 - - 3,188
2015-07-21 Bishop John L Chairman of the Board and CEO Exercice d'Options (Vente) 1,218 - - 13,407
2015-06-02 Madden Dan EVP, Chief Financial Officer Cession 18,000 $44.64 $803.52K -
2015-06-02 Madden Dan Acting Chief Financial Officer Cession 18,000 - - -
2015-05-10 Steele Glenn Jr Md Phd Director Attribution de RSU 257 $56.99 $14.65K 12,716
■ Informatif — transaction sur marché ouvert (la plus significative) ■ Non informatif (achat) — récompense, exercice d'option, conversion ■ Non informatif (vente) — retenue fiscale, vente à l'acquisition ■ Neutre — don, fiducie, expiration

Les autres consultent aussi

LLY
LLY
Eli Lilly and Company
$922.50
-0.76%
 JNJ
JNJ
Johnson & Johnson
$240.10
+0.90%
 ABBV
ABBV
AbbVie Inc.
$210.32
+1.86%
 RHHBF
RHHBF
Roche Holding AG
$418.50
+1.82%
 RHHBY
RHHBY
Roche Holding AG
$51.02
+0.65%
 AZN
AZN
AstraZeneca PLC
$204.38
+1.06%
 NVSEF
NVSEF
Novartis AG
$156.48
+0.00%
 MRK
MRK
Merck & Co., Inc.
$119.96
-0.16%
Contactez-nous
🎓
SharesGrow Académie
Apprenez à calculer la Valeur Intrinsèque et trouver des actions sous-évaluées.
Sessions hebdomadaires en direct
📧 [email protected]
📞 +65 8912 8000
Envoyez-nous un message